New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 4, 2014
10:27 EDTHEB, TKMR, BCRX, NNVCMapp drug used to treat Ebola patients, CNN reports
A drug made by privately held Mapp Biopharmaceutical was used to treat the two Americans who contracted Ebola, CNN reports, citing a source familiar with details of the treatment. The experimental treatment called ZMapp had never been tried before in a human but had showed promise with monkeys, CNN adds. Shares of Tekmira (TKMR), NanoViricides (NNVC), BioCryst (BCRX) and Hemispherx (HEB) are moving higher in early trading after two Americans were flown home with Ebola. Reference Link
News For TKMR;NNVC;BCRX;HEB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 18, 2015
15:17 EDTBCRXBioCryst management to meet with JPMorgan
Subscribe for More Information
May 13, 2015
07:00 EDTBCRXBioCryst initiates Phase 1 clinical trial of angioedema candidate
Subscribe for More Information
May 11, 2015
08:41 EDTHEBHemispherx Biopharma Europe receives orphan designation by EMA for Ampligen
Hemispherx announces that its European subsidiary, Hemispherx Biopharma Europe, received formal notification from the European Commission approving its Orphan Medicinal Product Application for Ampligen, an experimental therapeutic, to treat Ebola Virus Disease.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use